Gene therapy of hepatocellular carcinoma and gastrointestinal tumors

Annals of the New York Academy of Sciences

Volumn 963, Issue , 2002, Pages 6-12

  Sangro, Bruno ^a   Qian, Cheng ^a   Schmitz, Volker ^b   Prieto, Jesus ^a,c  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

^b UNIVERSITY HOSPITAL BONN   (Germany)

^c Universitaria de Navarra   (Spain)

Author keywords

CD40 ligand; Gastrointestinal neoplasms; Gene therapy; Genetic immunotherapy; Hepatocellular carcinoma; Interleukin 12; Thymidine kinase

Indexed keywords

ADENOVIRUS VECTOR; CD40 LIGAND; CHEMOKINE; GANCICLOVIR; INTERLEUKIN 12; NUCLEOSIDE ANALOG; PRODRUG; THYMIDINE KINASE;

ANGIOGENESIS; ANTINEOPLASTIC ACTIVITY; CANCER IMMUNOTHERAPY; COLORECTAL CANCER; CONFERENCE PAPER; DRUG EFFICACY; DRUG POTENCY; DRUG POTENTIATION; GASTROINTESTINAL TUMOR; GENE ACTIVATION; GENE THERAPY; GENE TRANSFER; GENETIC TRANSDUCTION; HUMAN; IMMUNOSTIMULATION; LIVER CANCER; LIVER CELL CARCINOMA; LIVER METASTASIS; NATURAL KILLER CELL; TUMOR IMMUNITY; TUMOR REGRESSION; TUMOR SUPPRESSOR GENE; VIRUS RECOMBINANT;

ADENOVIRIDAE; ANIMALIA;

EID: 0036291075     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2002.tb04089.x     Document Type: Conference Paper

References (31)

1. Human gene therapy comes of age
2. The basic science of gene therapy
3. Efficacy of repeated adenoviral suicide gene therapy in a localized murine tumor model
4. Primary liver tumors
5. Management of metastatic disease
6. Metastatic liver tumors
7. Hepatic resection for hepatocellular carcinoma. An audit of 343 patients
8. The potential of gene therapy in the treatment of hepatocellular carcinoma
9. Gene therapy of viral hepatitis and hepatocellular carcinoma
10. Gene therapy for gastrointestinal tract cancer: A review
11. Drug sensitivity ("suicide") genes for selective cancer chemotherapy
12. Induction of sensitivity to ganciclovir in human hepatocellular carcinoma cells by adenovirus-mediated gene transfer of herpes simplex virus thymidine kinase
13. In vivo evidence that metabolic cooperation is responsible for the bystander effect observed with HSV tk retroviral gene therapy
14. Combined gene therapy with suicide gene and interleukin-12 is more efficient than therapy with one gene alone in a murine model of hepatocellular carcinoma
15. Evaluation of prodrugs' ability to induce effective ablation of cells transduced with viral thymidine kinase gene
16. Gene transfer and therapy with adenoviral vector in rats with diethylnitrosamine-induced hepatocellular carcinoma
17. Effect of gene therapy with the herpes simplex virus-thymidine kinase gene on hepatic metastasis in murine colon cancer
18. Inhibition of establishment of hepatic metastasis in mice by combination gene therapy using both herpes simplex virus-thymidine kinase and granulocyte macrophage-colony stimulating factor genes in murine colon cancer
19. Intratumoral adenovirus-mediated suicide gene transfer for hepatic metastases from colorectal adenocarcinoma: Results of a phase I clinical trial
20. Immune response against tumors
21. Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells
22. Cytokine, tumor-cell death and immunogenicity: A question of choice
23. Cytokines and gene therapy
24. Cytokine gene transfer in tumor inhibition and tumor therapy: Where are we now?
25. Gene therapy of orthotopic hepatocellular carcinoma in rats using adenovirus coding for interleukin-12 (IL-12)
26. Antitumor and antimetastatic activity of interleukin 12 against murine tumors
27. Intratumoral coinjection of two adenoviruses, one encoding the chemokine IFN-gamma-inducible protein-10 and another encoding IL-12, results in marked antitumoral synergy
28. Adenoviral gene transfer of interleukin 12 into tumors synergizes with adoptive T cell therapy both at the induction and effector level
29. Gene transfer to liver cancer cells of B7-1 plus interleukin 12 changes immunoeffector mechanisms and suppresses helper T cell type 1 cytokine production induced by interleukin 12 alone
30. Gene therapy of colon carcinomas (CC) and hepatocellular carcinomas (HCC) by adenovirus-mediated in vivo gene transfer of CD40 ligand